Skip to content

The effects of an information provision intervention about menstruation aimed at male adolescents: a cohort-nested randomized controlled trial in Uganda as a part of Research Network for Design and Evaluation of Adolescent Health Interventions and Policies in Sub-Saharan Africa (DASH)

The effects of an information provision intervention about menstruation aimed at male adolescents: a cohort-nested randomized controlled trial in Uganda as a part of Research Network for Design and Evaluation of Adolescent Health Interventions and Policies in Sub-Saharan Africa (DASH)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00034169
Enrollment
666
Registered
2024-04-30
Start date
2024-05-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menstrual health

Interventions

Group 1: Control: This will be a pure control that participates in the survey, but receives no intervention. Group 2: Provision of information material about menstruation: The survey will be paused du

Sponsors

Heidelberg Institute of Global Health (HIGH)
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
10 Years to 19 Years

Inclusion criteria

Inclusion criteria: The following inclusion criteria are those for the overall DASH cohort, with the addition of restricting the RCT to male participants between ages 10 and 19 years: ? Study participant is between ages 10 and 19 years; ? Study participant is male; ? Minors (i.e. less than 18 years of age): the parents or guardians provide written informed consent, and the minor participant provides informed assent; ? Adults (i.e. 18 years of age and above): provides written informed consent; and, ? Study participant is a resident of the study area and intends to stay in the study area for the duration of the study.

Exclusion criteria

Exclusion criteria: The following exclusion criteria are those for the overall DASH cohort: ? Participants who do not meet the above-listed criteria will be excluded; ? Participants with chronic illnesses will be excluded since it may hinder their autonomy; ? Participants whose capacity to make meaningful decisions is in question because they are "cognitively impaired”; ? Individuals with communication difficulties. The only additional criteria applied specifically for this randomized trial is that the participant will be excluded from analysis if he does not respond to the questions that are used to generate the outcome measures.

Design outcomes

Primary

MeasureTime frame
Survey items: Interest in learning about menstruation (cross-sectionally at a later point in the survey, and again 1 year after intervention is provided, when the next wave of the survey is administered); Self-reported teasing behavior regarding menstruation (cross-sectionally at a later point in the survey, and again 1 year after intervention is provided, when the next wave of the survey is administered).

Secondary

MeasureTime frame
Survey items: Knowledge about the menstrual cycle (cross-sectionally at an earlier point in the survey, and again 1 year after intervention is provided, when the next wave of the survey is administered); Knowledge about fertility in the menstrual cycle (Cross-sectionally at an earlier point in the survey, and again 1 year after intervention is provided, when the next wave of the survey is administered); Discomfort with the topic of menstruation (cross-sectionally at a later point in the survey, and again 1 year after intervention is provided, when the next wave of the survey is administered); Perceived normality of menstruation (cross-sectionally at a later point in the survey, and again 1 year after intervention is provided, when the next wave of the survey is administered).

Countries

Uganda

Contacts

Public ContactDorit Ann

Heidelberg Institute of Global Health

ann@stud.uni-heidelberg.de+4915226284928

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026